Day One Biopharmaceuticals Inc (DAWN) Financials

$21.53

$0.00 (0.00%)

As on 24-Apr-2026 09:30EDT

Market cap

$2,225 Mln

Revenue (TTM)

$158 Mln

P/E Ratio

--

P/B Ratio

5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	158.18	131.16	--	--	--	--
Cost of Revenue	17.21	5.28	0.38	0.53	0.20	0.16
Gross Profit	140.97	125.88	-0.38	-0.53	-0.20	-0.16
Operating Expenses	268.72	343.15	206.06	146.91	72.74	13.78
Operating Profit (EBIT)	-127.75	-217.27	-206.06	-146.91	-72.74	-13.78
Other Income	--	--	--	--	-0.02	--
Profit before Tax	-109.30	-88.35	-188.92	-142.18	-72.75	-43.84
Provision for Tax	-1.98	7.14	--	-10.01	-2.31	-3.34
Profit after Tax (Net Income)	-107.32	-95.50	-188.92	-132.18	-70.44	-40.51
Minority Interest	--	--	--	--	-2.11	5.70
Consolidated Profit	-107.32	-95.50	-188.92	-142.18	-170.64	-40.51

Liabilities ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	441.16	502.75	346.54	332.04	281.15	37.76
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	6.14	6.59	--	0.41	0.02	0.20
Current Liabilities	60.52	73.45	29.51	16.62	8.66	2.00
Total Liabilities	507.83	582.79	376.05	349.06	289.82	45.66

Assets ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	22.73	20.46	0.77	1.19	0.45	0.59
Current Assets	485.10	562.33	375.27	347.87	289.37	45.07
Total Assets	507.83	582.79	376.05	349.06	289.82	45.66
Total Debt*	2.79	2.60	0.41	0.81	0.22	0.40
Net Current Assets	424.58	488.88	345.77	331.26	280.71	43.08

Cashflow ($ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-103.76	-78.11	-146.85	-109.87	-48.54	-13.49
Cash Flow from Investing Activities	174.65	-230.99	128.38	-255.07	-8.00	-0.09
Cash from Financing Activities	1.22	203.29	164.00	165.90	297.12	29.98
Net Cash Inflow / Outflow	--	--	--	-199.05	240.58	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-1.04	-1.02	-2.37	-2.02	-1.91	-0.65
Cash EPS ($)	-1.00	-1.00	-2.36	-2.01	-1.90	-0.65
Adjusted Book Value ($)	4.27	5.37	4.34	5.07	7.61	0.61
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	-1.00	-0.83	-1.84	-1.68	-1.31	-0.22
Free Cash Flow per Share ($)	-1.01	-0.86	-1.88	-1.68	-1.53	-0.22

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	-22.61	-22.41	-55.58	-43.04	-44.09	-294.72
ROE (%)	-22.74	-22.49	-55.68	-43.11	-44.18	-299.10
ROA (%)	-19.68	-19.92	-52.11	-41.38	-41.99	-110.98
EBIT Margin (%)	-80.76	-165.65	--	--	--	--
Net Margin (%)	-67.85	-72.81	--	--	469,613.33	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	0.21	--	--	--	--	--
EBIT Growth (%)	41.20	-5.44	-40.27	-101.96	-548.53	208.79
Net Profit Growth (%)	-12.38	49.45	-42.93	-87.64	-73.90	-220.62
EPS Growth (%)	-0.02	0.57	-0.17	-0.06	-1.91	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	-8.98	-12.42	-6.17	-10.66	-8.84	--
Price / Book Value	2.18	2.36	3.36	4.24	2.22	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.24	-3.05	-3.88	-7.29	-4.67	--
Close Price ($)	9.32	12.67	14.60	21.52	16.85	--
High Price ($)	13.53	18.07	25.77	28.35	28.70	--
Low Price ($)	5.64	11.94	9.67	5.44	15.16	--
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.01	0.01	0.00	0.00	0.00	0.01
Short term debt to equity ratio	0.00	0.00	0.00	0.00	0.00	0.01
Current Ratio	8.02	7.66	12.72	20.94	33.43	22.58
Quick Ratio	7.91	7.61	12.72	--	--	--
Interest Coverage	--	--	--	-30.95	-18,185.75	540.60

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	16.90	10.58	--	--	--	--
Asset Turnover	0.29	0.27	--	--	--	--
Receivable days	46.89	19.32	--	--	--	--
Inventory Days	102.37	114.89	--	--	--	--
Payable days	74.23	201.96	1,352.28	689.23	1,785.87	319.30
Cash Conversion Cycle	75.03	-67.75	--	--	--	--